186 related articles for article (PubMed ID: 10767798)
21. Intratumoral neoadjuvant immunotherapy using IL-12 and dendritic cells is an effective strategy to control recurrence of murine hepatocellular carcinoma in immunosuppressed mice.
Kayashima H; Toshima T; Okano S; Taketomi A; Harada N; Yamashita Y; Tomita Y; Shirabe K; Maehara Y
J Immunol; 2010 Jul; 185(1):698-708. PubMed ID: 20498356
[TBL] [Abstract][Full Text] [Related]
22. Combination therapy with suicide and cytokine genes for hepatic metastases of lung cancer.
Kwong YL; Chen SH; Kosai K; Finegold M; Woo SL
Chest; 1997 Nov; 112(5):1332-7. PubMed ID: 9367477
[TBL] [Abstract][Full Text] [Related]
23. Rapid production of interleukin-2-secreting tumor cells by herpes simplex virus-mediated gene transfer: implications for autologous vaccine production.
Tung C; Federoff HJ; Brownlee M; Karpoff H; Weigel T; Brennan MF; Fong Y
Hum Gene Ther; 1996 Dec; 7(18):2217-24. PubMed ID: 8953312
[TBL] [Abstract][Full Text] [Related]
24. IL-12 Expressing oncolytic herpes simplex virus promotes anti-tumor activity and immunologic control of metastatic ovarian cancer in mice.
Thomas ED; Meza-Perez S; Bevis KS; Randall TD; Gillespie GY; Langford C; Alvarez RD
J Ovarian Res; 2016 Oct; 9(1):70. PubMed ID: 27784340
[TBL] [Abstract][Full Text] [Related]
25. Specific organ gene transfer in vivo by regional organ perfusion with herpes viral amplicon vectors: implications for local gene therapy.
Brooks AD; Ng B; Liu D; Brownlee M; Burt M; Federoff HJ; Fong Y
Surgery; 2001 Mar; 129(3):324-34. PubMed ID: 11231461
[TBL] [Abstract][Full Text] [Related]
26. In vivo antitumor effect of herpes simplex virus thymidine kinase gene therapy in rat hepatocellular carcinoma: feasibility of adenovirus-mediated intra-arterial gene delivery.
Kwon HC; Kim JH; Kim KC; Lee KH; Lee JH; Lee BH; Lee KH; Jang JJ; Lee CT; Lee H; Kim CM
Mol Cells; 2001 Apr; 11(2):170-8. PubMed ID: 11355697
[TBL] [Abstract][Full Text] [Related]
27. Purified herpes simplex thymidine kinase Retrovector particles. I. In vitro characterization, in situ transduction efficiency, and histopathological analyses of gene therapy-treated brain tumors.
Kruse CA; Roper MD; Kleinschmidt-DeMasters BK; Banuelos SJ; Smiley WR; Robbins JM; Burrows FJ
Cancer Gene Ther; 1997; 4(2):118-28. PubMed ID: 9080121
[TBL] [Abstract][Full Text] [Related]
28. Treatment of murine hepatocellular carcinoma using genetically modified cells to express interleukin-12.
Peron JM; Couderc B; Rochaix P; Douin-Echinard V; Asnacios A; Souque A; Voigt JJ; Buscail L; Vinel JP; Favre G
J Gastroenterol Hepatol; 2004 Apr; 19(4):388-96. PubMed ID: 15012775
[TBL] [Abstract][Full Text] [Related]
29. A novel cancer vaccine strategy with combined IL-18 and HSV-TK gene therapy driven by the hTERT promoter in a murine colorectal cancer model.
Higashi K; Hazama S; Araki A; Yoshimura K; Iizuka N; Yoshino S; Noma T; Oka M
Int J Oncol; 2014 Oct; 45(4):1412-20. PubMed ID: 25051201
[TBL] [Abstract][Full Text] [Related]
30. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.
Fraefel C; Jacoby DR; Lage C; Hilderbrand H; Chou JY; Alt FW; Breakefield XO; Majzoub JA
Mol Med; 1997 Dec; 3(12):813-25. PubMed ID: 9440115
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant immunotherapy using fibroblasts genetically engineered to secrete interleukin 12 prevents recurrence after surgical resection of established tumors in a murine adenocarcinoma model.
Matsumoto G; Sunamura M; Shimamura H; Kodama T; Hashimoto W; Kobari M; Kato K; Takeda K; Yagita H; Okumura K; Hamada H; Matsuno S
Surgery; 1999 Mar; 125(3):257-64. PubMed ID: 10076609
[TBL] [Abstract][Full Text] [Related]
32. Comparison of laparoscopic versus conventional technique in colonic and liver resection in a tumor-bearing small animal model.
Kuntz C; Kienle P; Schmeding M; Benner A; Autschbach F; Schwalbach P
Surg Endosc; 2002 Aug; 16(8):1175-81. PubMed ID: 12189479
[TBL] [Abstract][Full Text] [Related]
33. Rapid recruitment of macrophages in interleukin-12-mediated tumour regression.
Ha SJ; Lee SB; Kim CM; Shin HS; Sung YC
Immunology; 1998 Sep; 95(1):156-63. PubMed ID: 9767471
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-12 gene transfer results in CD8-dependent regression of murine CT26 liver tumors.
Weber SM; Shi F; Heise C; Warner T; Mahvi DM
Ann Surg Oncol; 1999 Mar; 6(2):186-94. PubMed ID: 10082045
[TBL] [Abstract][Full Text] [Related]
35. Adenovirus-mediated CD40 ligand gene therapy in a rat model of orthotopic hepatocellular carcinoma.
Schmitz V; Barajas M; Wang L; Peng D; Duarte M; Prieto J; Qian C
Hepatology; 2001 Jul; 34(1):72-81. PubMed ID: 11431736
[TBL] [Abstract][Full Text] [Related]
36. Herpes simplex virus (HSV)-mediated ICAM-1 gene transfer abrogates tumorigenicity and induces anti-tumor immunity.
D'Angelica M; Tung C; Allen P; Halterman M; Delman K; Delohery T; Klimstra D; Brownlee M; Federoff H; Fong Y
Mol Med; 1999 Sep; 5(9):606-16. PubMed ID: 10551902
[TBL] [Abstract][Full Text] [Related]
37. Are hepatomas a good target for suicide gene therapy? An experimental study in rats using retroviral-mediated transfer of thymidine kinase gene.
Nagy H; Panis Y; Fabre M; Perrin H; Klatzmann D; Houssin D
Surgery; 1998 Jan; 123(1):19-24. PubMed ID: 9457219
[TBL] [Abstract][Full Text] [Related]
38. Low-dose adenoviral immunotherapy of rat hepatocellular carcinoma using single-chain interleukin-12.
Waehler R; Ittrich H; Mueller L; Krupski G; Ameis D; Schnieders F
Hum Gene Ther; 2005 Mar; 16(3):307-17. PubMed ID: 15812226
[TBL] [Abstract][Full Text] [Related]
39. Immunomodulatory gene therapy with interleukin 12 and 4-1BB ligand: long- term remission of liver metastases in a mouse model.
Martinet O; Ermekova V; Qiao JQ; Sauter B; Mandeli J; Chen L; Chen SH
J Natl Cancer Inst; 2000 Jun; 92(11):931-6. PubMed ID: 10841829
[TBL] [Abstract][Full Text] [Related]
40. Ischemia-reperfusion of small liver remnant promotes liver tumor growth and metastases--activation of cell invasion and migration pathways.
Man K; Ng KT; Lo CM; Ho JW; Sun BS; Sun CK; Lee TK; Poon RT; Fan ST
Liver Transpl; 2007 Dec; 13(12):1669-77. PubMed ID: 18044786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
